Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Vaxcyte, Inc. vs Spyre Therapeutics, Inc.: key figures
| Rank | #1939 | #2017 |
|---|---|---|
| Price | $67.53 | $109.00 |
| Market cap | $10.63B | $10.06B |
| Shares Outstanding | 157.39M | 92.29M |
| Change (1 day) | +5.70% | +4.95% |
| Change (1 year) | +48.25% | +381.66% |
The other way round: SYRE with the market cap of PCVX
If Spyre Therapeutics, Inc. (SYRE) had the market cap of Vaxcyte, Inc. (PCVX), one SYRE would cost $115.16, 1.06 times today's price of $109.00.
Price of SYRE with the Market Cap of PCVXPrice of PCVX with the Market Cap of SYRE: the last 12 months
The price of one PCVX if Vaxcyte, Inc. had the market cap of Spyre Therapeutics, Inc., at the end of each month. Highest: $220.22 (Jun 2026). Lowest: $17.59 (Jan 2026).
- $18.02 Dec 2025
- $17.59 Jan 2026
- $109.36 Feb 2026
- $128.26 Mar 2026
- $189.31 Apr 2026
- $182.32 May 2026
- $220.22 Jun 2026
- $59.22 Jul 2026
- $53.72 Aug 2026
- $53.54 Sep 2026
- $56.62 Oct 2026
- $63.92 Nov 2026
Questions about Vaxcyte, Inc. and Spyre Therapeutics, Inc.
What would the price of Vaxcyte, Inc. be with the market cap of Spyre Therapeutics, Inc.?
If Vaxcyte, Inc. (PCVX) had the market cap of Spyre Therapeutics, Inc. (SYRE), one PCVX would cost $63.92, 5.35% less than today's price of $67.53.
How much bigger is Vaxcyte, Inc. than Spyre Therapeutics, Inc.?
The market cap of Vaxcyte, Inc. ($10.63B) is 1.06 times that of Spyre Therapeutics, Inc. ($10.06B). In Dec 2025 the gap was 2.56 times.
What would the price of Spyre Therapeutics, Inc. be with the market cap of Vaxcyte, Inc.?
If Spyre Therapeutics, Inc. (SYRE) had the market cap of Vaxcyte, Inc. (PCVX), one SYRE would cost $115.16, 1.06 times today's price of $109.00.
How is this price calculated?
The market cap of Spyre Therapeutics, Inc. ($10.06B) is divided by the number of PCVX in circulation (157.39M). Market cap is the price multiplied by the number of coins or shares in circulation.